Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease
Objective: To report the efficacy and safety profiles of patients on sustained foslevodopa/foscarbidopa (LDP/CDP) continuous subcutaneous infusion (CSCI) mono- or polytherapy from three phase 3…Unsupervised physical capacity testing at home: a systematic review
Objective: Systematically review home-based physical capacity tests and their clinimetric properties in different patient populations with a chronic disease. Background: Physical capacity is a predictor…IParkours : Role of the advanced practice nurse (APN) in the support/follow-up of parkinsonian patients.
Objective: Specify the contribution of APN in the follow up of patient (prescription, follow-up rate, health literacy).Expected evolution to increase the impact of the physician.Fluidify…Nutritional traits in the prodromal phase on Parkinson’s disease in community-dwelling older adults in Japan
Objective: The objects of this study is to clarify the relationship between nutritional traits and the prodromal phase of PD in the community-dwelling older adults.…Role of the direct subthalamo-cerebellar tract in memory and learning: Implications for the pathophysiology of late-stage Parkinson’s Disease
Objective: To study the role of the recently identified direct subcortical cerebellum basal ganglia (C-BG) network in the pathophysiology of Parkinson’s Disease (PD). Background: Even…Decreased occurrence of dyskinesia when combining amantadine to L-DOPA in early Parkinson disease (PD): the PREMANDYSK trial
Objective: To assess amantadine effects on dyskinesia and other PD symptoms when adjunct to L-DOPA in early PD. Background: Amantadine is efficacious on L-DOPA-induced dyskinesia…Therapeutic effects of citral nanoliposome on Parkinson’s treatment in a rat model: Modulation via neurochemical, inflammatory and antioxidant pathways
Objective: The present study aimed to assess the effects of citral nanoliposome on Parkinson's treatment in a rat model. Background: Parkinson's disease is the most…Dopamine transporter in the brain is linked to irritable bowel syndrome in Parkinson´s disease
Objective: To assess correlations between gastrointestinal symptoms and dopamine transporter (DAT) changes in striatal and extrastriatal areas in Parkinson´s disease (PD) patients. Background: Gastrointestinal symptoms…Clinic versus home dose optimization of apomorphine sublingual film in Parkinson’s Disease: cross-study comparison of safety
Objective: To compare the safety profile of clinic versus home dose optimization of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease experiencing OFF episodes.…Psychosocial factors impacting participation in a time-intensive deep brain stimulation study of individuals with Parkinson’s disease and dystonia
Objective: To evaluate psychosocial factors impacting the number of hours of participation in the first five months of a time-intensive deep brain stimulation (DBS) study.…
- « Previous Page
- 1
- …
- 221
- 222
- 223
- 224
- 225
- …
- 436
- Next Page »